Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia

NCT01940198 | Completed

• 1 other identifier: AI424-417 ST
• Study Type: observational
• Target: 117
• Locations: 1 country
• Sites: 1

Brief Summary

This observational study will aim to determine long-term atazanavir experience in a high HIV caseload primary care practice in Sydney, Australia.

Conditions

HIV

Keywords

Atazanavir; long-term; primary care setting; sydney

Outcome Measures

Primary Outcomes (1)

• Proportion of HIV-1 infected participants with atazanavir experience

  Proportion of patients who continue on atazanavir for 2 years or greater from baseline to termination/current.

  1 year

Secondary Outcomes (4)

• Proportion of HIV-1 infected participants with atazanavir experience

  1 year

• Proportion of HIV-1 infected participants with atazanavir experience

  1 year

• Proportion of HIV-1 infected participants with atazanavir experience

  1 year

• Proportion of HIV-1 infected participants with atazanavir experience

  1 year

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Cohort of HIV-1 positive patients attending Holdsworth House Medical Practice who have commenced ATV as a component of ART will be identified from review of current database. Data will be collected retrospectively from patient electronic medical records for HIV-1 positive patients that have commenced ATV from year 2002 - 2008.

You may qualify if:

• HIV-1 positive
• Have commenced ATV between 2002-2008 (Baseline)
• Follow-up data (clinical and laboratory) available from baseline

You may not qualify if:

• Patients not commenced ATV between 2002-2008
• No follow-up data (clinical and laboratory) available from baseline
• Patient 'lost to follow-up' with \< 2 years of follow-up data (Clinical and laboratory)

Sponsors & Collaborators

• Holdsworth House Medical Practice: lead
• Bristol-Myers Squibb: collaborator

Study Sites (1)

Holdsworth House Medical Practice

Sydney, New South Wales, 2010, Australia

Location

Study Officials

• Mark Bloch, Dr.

  Holdsworth House Medical Practice

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 1, 2010
• First Posted: September 12, 2013
• Study Start: April 1, 2010
• Primary Completion: August 1, 2011
• Study Completion: September 1, 2012
• Last Updated: September 12, 2013

Record last verified: 2013-09

Locations

AU (1)